Prevalence and correlates of major depressive symptoms among black men with prostate cancer

Ballington L. Kinlock, Lauren Parker, Daniel L. Howard, Janice Bowie, Thomas A. LaVeist, Roland J Thorpe

Research output: Contribution to journalArticle

Abstract

Objective: The objectives of our study were to determine the prevalence of major depressive symptoms and identify factors that are associated with major depressive symptoms among Black men with prostate cancer (PCa). Design: This study consisted of 415 Black men aged 40-81 years that entered the North Carolina Central Cancer Registry during the years 2007-2008. The primary outcome variable was depressive symptoms (CES-D). Factors included age, income, education, insurance status, treatment received, time between diagnosis and treatment, Gleason score, medical mistrust and experience with racism/discrimination. Logistic regression models were used to assess factors associated with the odds of having major depressive symptoms. Results: The prevalence of major depressive symptoms (≥16 on CES-D) among our sample of Black men with PCa was approximately 33%. Approximately 15% of the study participants underwent radiation beam treatment. Age was significantly associated with the odds of reporting major depressive symptoms (OR= .95, CI .91-.99) among Black men. In addition, compared with all other forms of treatment, Black men who underwent radiation beam treatment had higher odds (OR=2.38, CI 1.02-5.51) of reporting major depressive symptoms. Conclusion: Nearly one-third of Black men with PCa in this study reported major depressive symptoms. Clinicians should pay closer attention to the mental health status of Black men with PCa, especially those who are younger and those who have undergone radiation beam treatment. Cancer survivorship, particularly quality of life, may be enhanced by opportunities for assessment, evaluation and intervention of depressive symptoms among these men disproportionately affected by PCa.

Original languageEnglish (US)
Pages (from-to)429-436
Number of pages8
JournalEthnicity and Disease
Volume27
Issue number4
DOIs
StatePublished - Sep 1 2017

Fingerprint

Prostatic Neoplasms
Depression
Radiation
Therapeutics
Logistic Models
Racism
Insurance Coverage
Neoplasm Grading
Age Factors
Health Status
Registries
Neoplasms
Mental Health
Survival Rate
Quality of Life
Education

Keywords

  • Black men
  • Cancer disparity
  • Depression
  • Major depressive symptoms
  • Prostate cancer

ASJC Scopus subject areas

  • Epidemiology

Cite this

Prevalence and correlates of major depressive symptoms among black men with prostate cancer. / Kinlock, Ballington L.; Parker, Lauren; Howard, Daniel L.; Bowie, Janice; LaVeist, Thomas A.; Thorpe, Roland J.

In: Ethnicity and Disease, Vol. 27, No. 4, 01.09.2017, p. 429-436.

Research output: Contribution to journalArticle

Kinlock, Ballington L. ; Parker, Lauren ; Howard, Daniel L. ; Bowie, Janice ; LaVeist, Thomas A. ; Thorpe, Roland J. / Prevalence and correlates of major depressive symptoms among black men with prostate cancer. In: Ethnicity and Disease. 2017 ; Vol. 27, No. 4. pp. 429-436.
@article{eb8c99d85eb04ea9a1235b83dff62042,
title = "Prevalence and correlates of major depressive symptoms among black men with prostate cancer",
abstract = "Objective: The objectives of our study were to determine the prevalence of major depressive symptoms and identify factors that are associated with major depressive symptoms among Black men with prostate cancer (PCa). Design: This study consisted of 415 Black men aged 40-81 years that entered the North Carolina Central Cancer Registry during the years 2007-2008. The primary outcome variable was depressive symptoms (CES-D). Factors included age, income, education, insurance status, treatment received, time between diagnosis and treatment, Gleason score, medical mistrust and experience with racism/discrimination. Logistic regression models were used to assess factors associated with the odds of having major depressive symptoms. Results: The prevalence of major depressive symptoms (≥16 on CES-D) among our sample of Black men with PCa was approximately 33{\%}. Approximately 15{\%} of the study participants underwent radiation beam treatment. Age was significantly associated with the odds of reporting major depressive symptoms (OR= .95, CI .91-.99) among Black men. In addition, compared with all other forms of treatment, Black men who underwent radiation beam treatment had higher odds (OR=2.38, CI 1.02-5.51) of reporting major depressive symptoms. Conclusion: Nearly one-third of Black men with PCa in this study reported major depressive symptoms. Clinicians should pay closer attention to the mental health status of Black men with PCa, especially those who are younger and those who have undergone radiation beam treatment. Cancer survivorship, particularly quality of life, may be enhanced by opportunities for assessment, evaluation and intervention of depressive symptoms among these men disproportionately affected by PCa.",
keywords = "Black men, Cancer disparity, Depression, Major depressive symptoms, Prostate cancer",
author = "Kinlock, {Ballington L.} and Lauren Parker and Howard, {Daniel L.} and Janice Bowie and LaVeist, {Thomas A.} and Thorpe, {Roland J}",
year = "2017",
month = "9",
day = "1",
doi = "10.18865/ed.27.4.429",
language = "English (US)",
volume = "27",
pages = "429--436",
journal = "Ethnicity and Disease",
issn = "1049-510X",
publisher = "ISHIB",
number = "4",

}

TY - JOUR

T1 - Prevalence and correlates of major depressive symptoms among black men with prostate cancer

AU - Kinlock, Ballington L.

AU - Parker, Lauren

AU - Howard, Daniel L.

AU - Bowie, Janice

AU - LaVeist, Thomas A.

AU - Thorpe, Roland J

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Objective: The objectives of our study were to determine the prevalence of major depressive symptoms and identify factors that are associated with major depressive symptoms among Black men with prostate cancer (PCa). Design: This study consisted of 415 Black men aged 40-81 years that entered the North Carolina Central Cancer Registry during the years 2007-2008. The primary outcome variable was depressive symptoms (CES-D). Factors included age, income, education, insurance status, treatment received, time between diagnosis and treatment, Gleason score, medical mistrust and experience with racism/discrimination. Logistic regression models were used to assess factors associated with the odds of having major depressive symptoms. Results: The prevalence of major depressive symptoms (≥16 on CES-D) among our sample of Black men with PCa was approximately 33%. Approximately 15% of the study participants underwent radiation beam treatment. Age was significantly associated with the odds of reporting major depressive symptoms (OR= .95, CI .91-.99) among Black men. In addition, compared with all other forms of treatment, Black men who underwent radiation beam treatment had higher odds (OR=2.38, CI 1.02-5.51) of reporting major depressive symptoms. Conclusion: Nearly one-third of Black men with PCa in this study reported major depressive symptoms. Clinicians should pay closer attention to the mental health status of Black men with PCa, especially those who are younger and those who have undergone radiation beam treatment. Cancer survivorship, particularly quality of life, may be enhanced by opportunities for assessment, evaluation and intervention of depressive symptoms among these men disproportionately affected by PCa.

AB - Objective: The objectives of our study were to determine the prevalence of major depressive symptoms and identify factors that are associated with major depressive symptoms among Black men with prostate cancer (PCa). Design: This study consisted of 415 Black men aged 40-81 years that entered the North Carolina Central Cancer Registry during the years 2007-2008. The primary outcome variable was depressive symptoms (CES-D). Factors included age, income, education, insurance status, treatment received, time between diagnosis and treatment, Gleason score, medical mistrust and experience with racism/discrimination. Logistic regression models were used to assess factors associated with the odds of having major depressive symptoms. Results: The prevalence of major depressive symptoms (≥16 on CES-D) among our sample of Black men with PCa was approximately 33%. Approximately 15% of the study participants underwent radiation beam treatment. Age was significantly associated with the odds of reporting major depressive symptoms (OR= .95, CI .91-.99) among Black men. In addition, compared with all other forms of treatment, Black men who underwent radiation beam treatment had higher odds (OR=2.38, CI 1.02-5.51) of reporting major depressive symptoms. Conclusion: Nearly one-third of Black men with PCa in this study reported major depressive symptoms. Clinicians should pay closer attention to the mental health status of Black men with PCa, especially those who are younger and those who have undergone radiation beam treatment. Cancer survivorship, particularly quality of life, may be enhanced by opportunities for assessment, evaluation and intervention of depressive symptoms among these men disproportionately affected by PCa.

KW - Black men

KW - Cancer disparity

KW - Depression

KW - Major depressive symptoms

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=85038809470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038809470&partnerID=8YFLogxK

U2 - 10.18865/ed.27.4.429

DO - 10.18865/ed.27.4.429

M3 - Article

C2 - 29225444

AN - SCOPUS:85038809470

VL - 27

SP - 429

EP - 436

JO - Ethnicity and Disease

JF - Ethnicity and Disease

SN - 1049-510X

IS - 4

ER -